FI920342A0 - Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav. - Google Patents

Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav.

Info

Publication number
FI920342A0
FI920342A0 FI920342A FI920342A FI920342A0 FI 920342 A0 FI920342 A0 FI 920342A0 FI 920342 A FI920342 A FI 920342A FI 920342 A FI920342 A FI 920342A FI 920342 A0 FI920342 A0 FI 920342A0
Authority
FI
Finland
Prior art keywords
koaguleringsfaktor
komplex
foerfarande foer
foer framstaellning
och foerfarande
Prior art date
Application number
FI920342A
Other languages
English (en)
Other versions
FI920342L (fi
FI100111B (fi
Inventor
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI920342A0 publication Critical patent/FI920342A0/fi
Publication of FI920342L publication Critical patent/FI920342L/fi
Application granted granted Critical
Publication of FI100111B publication Critical patent/FI100111B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI920342A 1991-01-25 1992-01-24 Hyytymistekijää IX sisältävä kompleksi ja menetelmä sen valmistamiseks i FI100111B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0016391A AT402261B (de) 1991-01-25 1991-01-25 Komplex enthaltend den gerinnungsfaktor ix

Publications (3)

Publication Number Publication Date
FI920342A0 true FI920342A0 (fi) 1992-01-24
FI920342L FI920342L (fi) 1992-07-26
FI100111B FI100111B (fi) 1997-09-30

Family

ID=3483232

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920342A FI100111B (fi) 1991-01-25 1992-01-24 Hyytymistekijää IX sisältävä kompleksi ja menetelmä sen valmistamiseks i

Country Status (12)

Country Link
US (2) US5281661A (fi)
EP (1) EP0496725B1 (fi)
JP (2) JP2651307B2 (fi)
AT (2) AT402261B (fi)
CA (1) CA2059979C (fi)
CZ (2) CZ280725B6 (fi)
DE (1) DE59207638D1 (fi)
DK (1) DK0496725T3 (fi)
ES (1) ES2098485T3 (fi)
FI (1) FI100111B (fi)
HU (1) HU212362B (fi)
SK (2) SK280130B6 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU671586B2 (en) * 1991-03-01 1996-09-05 Aventis Behring Llc Preparation of factor IX
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
US5888826A (en) * 1994-06-30 1999-03-30 Dade Behring Inc. Combination reagent holding and test device
ES2163519T3 (es) 1994-06-30 2002-02-01 Dade Behring Inc Miembros separadores bioactivos porosos.
US5602037A (en) * 1994-06-30 1997-02-11 Dade International, Inc. Combination reagent holding and test device
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US5958716A (en) * 1996-06-06 1999-09-28 Dade Behring Inc. Blood factor assay
CN1284881A (zh) * 1997-11-05 2001-02-21 吉富制药株式会社 肝素辅助因子ⅱ制剂及其制备方法
JP4855074B2 (ja) * 2003-09-30 2012-01-18 一般財団法人化学及血清療法研究所 高純度血液凝固ｉｘ因子調製物およびその精製方法
KR101100059B1 (ko) * 2004-06-30 2011-12-29 넥타르 테라퓨틱스 중합체­인자 ｉｘ 부분의 접합체
AU2005318106B2 (en) * 2004-12-23 2011-11-03 Novo Nordisk Health Care Ag Reduction of the content of protein contaminants in compositions comprising a Vitamin K-dependent protein of interest
KR101464032B1 (ko) 2009-05-27 2014-11-27 백스터 인터내셔널 인코포레이티드 피하 사용을 위한 고 농축 면역글로불린 제제의 제조 방법
IN2012DN03219A (fi) 2009-09-17 2015-10-23 Baxter Healthcare Sa
JP6055412B2 (ja) 2010-09-17 2016-12-27 バクスアルタ ゲーエムベーハー 弱酸性〜中性のｐＨにおける、ヒスチジンを有する水性製剤を介した免疫グロブリンの安定化
JP6088435B2 (ja) 2010-12-15 2017-03-01 バクスアルタ ゲーエムベーハー 導電率グラディエントを用いる溶出液収集
CA2864868A1 (en) 2011-02-25 2012-11-15 Wellstat Diagnostics, Llc Assays for detecting enzymatic activity
AU2024351533A1 (en) 2023-09-26 2026-03-19 Takeda Pharmaceutical Company Limited IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
DE3751605D1 (de) * 1986-01-06 1996-01-04 Blood Systems Inc Therapeutisches Blutprodukt, Mittel und Verfahren zu dessen Erzeugung.
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
DE3914869C1 (fi) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
HU9200225D0 (en) 1992-04-28
HUT63863A (en) 1993-10-28
DK0496725T3 (da) 1997-06-09
CZ280297B6 (cs) 1995-12-13
ATA16391A (de) 1996-08-15
CS21192A3 (en) 1992-08-12
ES2098485T3 (es) 1997-05-01
FI920342L (fi) 1992-07-26
AT402261B (de) 1997-03-25
CA2059979C (en) 2003-04-15
JPH08259449A (ja) 1996-10-08
DE59207638D1 (de) 1997-01-23
EP0496725A2 (de) 1992-07-29
US5281661A (en) 1994-01-25
EP0496725A3 (en) 1993-05-05
EP0496725B1 (de) 1996-12-11
US5409990A (en) 1995-04-25
CZ154794A3 (en) 1996-04-17
JPH04295432A (ja) 1992-10-20
CZ280725B6 (cs) 1996-04-17
SK280989B6 (sk) 2000-10-09
ATE146220T1 (de) 1996-12-15
FI100111B (fi) 1997-09-30
CA2059979A1 (en) 1992-07-26
SK280130B6 (sk) 1999-08-06
JP2651307B2 (ja) 1997-09-10
HU212362B (en) 1996-06-28
JP2866047B2 (ja) 1999-03-08

Similar Documents

Publication Publication Date Title
FI920342A0 (fi) Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav.
SE8206168D0 (sv) Preparations and process for preparation thereof
DE59009451D1 (de) Colestyramin als lipidsenker enthaltende präparate.
DK605786A (da) Stabiliserede human-vaevsplasminogenaktivator-praeparater
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
DK198785A (da) 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconatog farmaceutiske praeparater som indeholder dette stof
ATE106395T1 (de) Disubstituierte (chinolin-2-yl-methoxy) phenylessigsäure-derivate.
FI893908A0 (fi) Framstaellning av transdermala laekemedel som innehaoller steroliner och/eller spiroketaliner.
ATE276357T1 (de) Reinigung von vitamin-k abhaengigen proteinen durch membrane chromatographie
DK188286A (da) Phenylalkyl-2,3-dihydrobenzofuraner og analoge heraf samt praeparater indeholdende disse forbindelser
FI916120A0 (fi) Foerfarande foer framstaellning av vattenhaltiga liposomsuspensioner som innehaoller ett aktivt aemne.
GR880100869A (el) Μέ?οδος παρασκευής παραγώγων υποκατεστημένου στυρολίου.
DK1001942T3 (da) Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser
ATE33389T1 (de) Derivat eines ethers von n-propanolamin.
MX9102087A (es) Complejos que contienen acidos s(+) fenilalcanos y acidos alfa-hidroxi alcanos.
SE8002244L (sv) Nytt 1alfa,25-dihydroxi-cholekalciferolderivat, sett for framstellning samt anvendning derav som lekemedel och farmaceutiska kompositioner inehallande denna forening
JPS5234981A (en) Production of alcohol from cellulose
DE59610098D1 (de) Protein mit anti-tumorwirkung
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
FI852537A0 (fi) Foerfaranden och medel vid biologisk behandling.
FI851867A7 (fi) Membraania stabiloivat yhdisteet ja farmaseuttiset valmisteet sekä menetelmät näiden yhdisteiden käyttämiseksi.
IT8222481V0 (it) Quadro cartografico per uffici, scuole, tridimensionale.
JPS56117791A (en) Purification of kallikrein
FI854934A0 (fi) Metod foer tillvaratagande och komprimering av slam, som uppstaor vid fiskodling.